Repositori Institucional UIB
Publication
Artículo científico (JournalArticle)
GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility
[eng] Coronavirus disease 19 (COVID-19) is a persistent global pandemic with a very heterogeneous disease presentation ranging from a mild disease to dismal prognosis. Early detection of sensitivity and severity of COVID-19 is essential for the development of new treatments. In the present study, we measured the levels of circulating growth differentiation factor 15 (GDF15) and angiotensin-converting enzyme 2 (ACE2) in plasma of severity-stratified COVID-19 patients and uninfected control patients and characterized the <em>in vitro</em> effects and cohort frequency of ACE2 SNPs. Our results show that while circulating GDF15 and ACE2 stratify COVID-19 patients according to disease severity, ACE2 missense SNPs constitute a risk factor linked to infection susceptibility.
Project:
ISCIII / Margalida Comas Program MS19-00201
,
ISCIII / FOLIUM fellowship program MS19-00100
,
Fondo extraordinario COVID
—ISCIII / TECH fellowship program COV20-00571
,
Fundació LaMarató TV3 167-
C-2021 51
,
CAIB PD-050-2020
,
GOIB FOLIUM 19-01
,
GOIB TECH19-03
View at: http://hdl.handle.net/11201/172558